Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Satoh · SciRah

Researcher profile · Semantic Scholar

T. Satoh

Share profile

T. Satoh — researcher profile on SciRah

h-index: 53
Works: 435
Citations: 23K

Most-cited papers

Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study.
A. Dasari, S. Lonardi, R. García-Carbonero, E. Élez +33 more
2023The Lancet271 citations Open access
Semantic Scholar
Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study
Lin Shen, Ken Kato, Sung-Bae Kim, J. Ajani +26 more
2022Journal of Clinical Oncology223 citations Open access
Semantic Scholar
Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma
Shu-Kui Qin, M. Kudo, T. Meyer, Yuxian Bai +12 more
2023JAMA Oncology210 citations Open access
Semantic Scholar
Effects of Metastatic Sites on Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer
H. Bando, Yoshiaki Nakamura, H. Taniguchi, M. Shiozawa +22 more
2022JCO Precision Oncology94 citations
Semantic Scholar
Circulating Tumor DNA Analysis Detects FGFR2 Amplification and Concurrent Genomic Alterations Associated with FGFR Inhibitor Efficacy in Advanced Gastric Cancer
Tomoko Jogo, Yoshiaki Nakamura, K. Shitara, H. Bando +24 more
2021Clinical Cancer Research51 citations Open access
Semantic Scholar
Multicenter randomised trial of two versus three courses of preoperative cisplatin and fluorouracil plus docetaxel for locally advanced oesophageal squamous cell carcinoma
T. Makino, M. Yamasaki, Koji Tanaka, K. Yamashita +15 more
2022British Journal of Cancer36 citations Open access
Semantic Scholar
First-line pembrolizumab + chemotherapy in Japanese patients with advanced/metastatic esophageal cancer from KEYNOTE-590
T. Kojima, H. Hara, A. Tsuji, H. Yasui +12 more
2022Esophagus35 citations Open access
Semantic Scholar
The tissue-resident marker CD103 on peripheral blood T cells predicts responses to anti-PD-1 therapy in gastric cancer
Y. Nose, Takuro Saito, Kei Yamamoto, K. Yamashita +14 more
2022Cancer Immunology and Immunotherapy30 citations Open access
Semantic Scholar
First-line pembrolizumab plus chemotherapy for advanced/metastatic esophageal cancer: 1-year extended follow-up in the Japanese subgroup of the phase 3 KEYNOTE-590 study
K. Kato, T. Kojima, H. Hara, Akihito Tsuji +12 more
2024Esophagus26 citations Open access
Semantic Scholar
Validity and utility of blood tumor mutational burden (bTMB) is dependent on circulating tumor DNA (ctDNA) shed: SCRUM-Japan MONSTAR-SCREEN
S. Mishima, Yoshiaki Nakamura, H. Tukachinsky, H. Taniguchi +19 more
2023The journal of liquid biopsy26 citations Open access
Semantic Scholar
Specific activation of glycolytic enzyme enolase 2 in BRAF V600E‐mutated colorectal cancer
Ryohei Yukimoto, N. Nishida, Tsuyoshi Hata, Shiki Fujino +9 more
2021Cancer Science25 citations Open access
Semantic Scholar
Clinical Validity of Plasma-Based Genotyping for Microsatellite Instability Assessment in Advanced GI Cancers: SCRUM-Japan GOZILA Substudy
Yoshiaki Nakamura, W. Okamoto, T. Denda, T. Nishina +30 more
2022JCO Precision Oncology24 citations Open access
Semantic Scholar
Two versus three courses of preoperative cisplatin and fluorouracil plus docetaxel for treating locally advanced esophageal cancer: short-term outcomes of a multicenter randomized phase II trial
O. Shiraishi, T. Makino, M. Yamasaki, Koji Tanaka +13 more
2021Esophagus22 citations
Semantic Scholar
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study
Yoon-Koo Kang, S. Morita, T. Satoh, M. Ryu +22 more
2021Gastric Cancer21 citations Open access
Semantic Scholar
Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07)
T. Satoh, Ken Kato, T. Ura, Y. Hamamoto +13 more
2021Esophagus17 citations Open access
Semantic Scholar
Tissue-agnostic efficacy of trastuzumab deruxtecan (T-DXd) in advanced solid tumors with HER2 amplification identified by plasma cell-free DNA (cfDNA) testing: Results from a phase 2 basket trial (HERALD/EPOC1806).
H. Taniguchi, M. Yagisawa, T. Satoh, S. Kadowaki +16 more
2023Journal of Clinical Oncology16 citations Open access
Semantic Scholar
Safety and tolerability of andecaliximab as monotherapy and in combination with an anti-PD-1 antibody in Japanese patients with gastric or gastroesophageal junction adenocarcinoma: a phase 1b study
Akie Kimura Yoshikawa, K. Yamaguchi, K. Muro, A. Takashima +12 more
2022Journal for ImmunoTherapy of Cancer14 citations Open access
Semantic Scholar
Clinical outcomes of neoadjuvant chemotherapy for resectable colorectal liver metastasis with intermediate risk of postoperative recurrence: A multi‐institutional retrospective study
T. Noda, Hidekazu Takahashi, Mitsuyoshi Tei, N. Nishida +41 more
2022Annals of Gastroenterological Surgery12 citations Open access
Semantic Scholar
Real-world effectiveness of third- or later-line treatment in Japanese patients with HER2-positive, unresectable, recurrent or metastatic gastric cancer: a retrospective observational study
D. Sakai, T. Omori, S. Fumita, J. Fujita +18 more
2022International Journal of Clinical Oncology12 citations Open access
Semantic Scholar
Impact of a metastatic site on circulating tumor DNA (ctDNA) analysis in patients (pts) with metastatic colorectal cancer (mCRC).
H. Bando, Yoshiaki Nakamura, H. Taniguchi, M. Shiozawa +16 more
202112 citations
Semantic Scholar
Randomized phase II study of docetaxel versus paclitaxel in patients with esophageal squamous cell carcinoma refractory to fluoropyrimidine- and platinum-based chemotherapy: OGSG1201.
S. Yamamoto, H. Kawakami, T. Kii, H. Hara +13 more
2021European Journal of Cancer12 citations Open access
Semantic Scholar
Health-related quality of life (HRQoL) associated with fruquintinib in the global phase 3, placebo-controlled, double-blind FRESCO-2 study.
A. Sobrero, A. Dasari, S. Lonardi, R. García-Carbonero +16 more
2023Journal of Clinical Oncology11 citations
Semantic Scholar
Efficacy of Targeted Trials and Signaling Pathway Landscape in Advanced Gastrointestinal Cancers From SCRUM-Japan GI-SCREEN: A Nationwide Genomic Profiling Program
Yoshiaki Nakamura, Riu Yamashita, W. Okamoto, Y. Komatsu +32 more
2023JCO Precision Oncology11 citations Open access
Semantic Scholar
Three-Course Neoadjuvant Chemotherapy Associated with Unfavorable Survival of Non-responders to the First Two Courses for Locally Advanced Esophageal Cancer
Yuto Kubo, T. Makino, M. Yamasaki, Koji Tanaka +14 more
2023Annals of Surgical Oncology11 citations
Semantic Scholar
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study)
K. Ando, Yoshiaki Nakamura, H. Kitao, M. Shimokawa +24 more
2023British Journal of Cancer11 citations Open access
Semantic Scholar
Abstract CT098: A first-in-human phase 1 study of LY3410738, a covalent inhibitor of mutant IDH, in advanced IDH-mutant cholangiocarcinoma and other solid tumors
J. Rodón, L. Goyal, T. M. Mercade, M. Ikeda +31 more
2023Cancer Research11 citations
Semantic Scholar
Neoadjuvant docetaxel, oxaliplatin and S-1 therapy for the patients with large type 3 or type 4 gastric cancer (OGSG1902): protocol of a multi-center, phase II study
S. Endo, T. Terazawa, M. Goto, R. Tanaka +8 more
2022BMC Cancer11 citations Open access
Semantic Scholar
Pivotal single-arm, phase 2 trial of tasurgratinib for patients with fibroblast growth factor receptor (FGFR)-2 gene fusion-positive cholangiocarcinoma (CCA).
J. Furuse, Bo Jiang, Takamichi Kuwahara, T. Satoh +16 more
2024Journal of Clinical Oncology10 citations Open access
Semantic Scholar
Phase II dose titration study of regorafenib in progressive unresectable metastatic colorectal cancer
Takeshi Kato, T. Kudo, Y. Kagawa, K. Murata +18 more
2023Scientific Reports10 citations Open access
Semantic Scholar
A phase 1b study of andecaliximab in combination with S-1 plus platinum in Japanese patients with gastric adenocarcinoma
A. Ooki, T. Satoh, K. Muro, A. Takashima +12 more
2022Scientific Reports10 citations Open access
Semantic Scholar
Pancreatic Cancer Research beyond DNA Mutations
Hiromichi Sato, K. Sasaki, T. Hara, Yoshiko Tsuji +12 more
2022Biomolecules9 citations Open access
Semantic Scholar
Pooled analysis of combination antiemetic therapy for chemotherapy-induced nausea and vomiting in patients with colorectal cancer treated with oxaliplatin-based chemotherapy of moderate emetic risk
M. Shimokawa, Toshinobu Hayashi, J. Nishimura, T. Satoh +5 more
2021BMC Cancer9 citations Open access
Semantic Scholar
Efficacy of Pembrolizumab Monotherapy in Japanese Patients with Advanced Gastric or Gastroesophageal Junction Cancer
K. Muro, K. Shitara, K. Yamaguchi, T. Yoshikawa +17 more
2023Journal of Gastrointestinal Cancer8 citations Open access
Semantic Scholar
Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAFV600E-Mutant Metastatic Colorectal Cancer: Results of the Japanese Expanded Access Program.
D. Kotani, A. Takashima, T. Kato, T. Satoh +15 more
2024Clinical colorectal cancer7 citations Open access
Semantic Scholar
The potential clinical utility of cell-free DNA for gastric cancer patients treated with nivolumab monotherapy
C. Inagaki, H. Kawakami, D. Maeda, D. Sakai +7 more
2023Scientific Reports7 citations Open access
Semantic Scholar
A phase II study of neoadjuvant capecitabine, oxaliplatin, and irinotecan (XELOXIRI) in patients with locally advanced rectal cancer
C. Matsuda, T. Kudo, Yoshihiro Morimoto, Y. Kagawa +11 more
2022Annals of Gastroenterological Surgery7 citations Open access
Semantic Scholar
A phase 2, open-label study of amivantamab in patients with previously treated advanced or metastatic gastric or esophageal cancer.
D. Kotani, K. Yamaguchi, K. Kato, H. Hara +12 more
2024Journal of Clinical Oncology6 citations Open access
Semantic Scholar
Effect of the number of cycles of docetaxel + S-1 therapy on long-term survival in adjuvant chemotherapy for stage III gastric cancer. A pooled analysis of the OGSG0604 and OGSG1002 trials
Y. Kimura, H. Kawakami, S. Tamura, K. Fujitani +9 more
2023Gastric Cancer6 citations Open access
Semantic Scholar
Efficacy of SOAT1 Inhibitors Against Pancreatic Cancer with TP53 Mutations
Ryosuke Maki, Y. Iwagami, Shogo Kobayashi, K. Sasaki +10 more
2025Annals of Surgical Oncology5 citations
Semantic Scholar
Neoadjuvant docetaxel, oxaliplatin, and S-1 therapy for patients with large type 3 or type 4 gastric cancer: short-term outcomes of a multicenter, phase II study (OGSG1902)
Ryo Tanaka, Shunji Endo, Toshifumi Yamaguchi, H. Miyagaki +15 more
2025Gastric Cancer5 citations
Semantic Scholar
Tissue-Resident Memory T Cells in Gastrointestinal Cancers: Prognostic Significance and Therapeutic Implications
Hiromichi Sato, Si-Kun Meng, T. Hara, Yoshiko Tsuji +9 more
2024Biomedicines5 citations Open access
Semantic Scholar
Nivolumab in advanced esophageal squamous cell carcinoma (ATTRACTION-1/ONO-4538-07): Minimum of five-year follow-up.
Ken Kato, Y. Doki, T. Ura, Y. Hamamoto +12 more
20215 citations
Semantic Scholar
Long‐Term Survival of Two Versus Three Courses of Preoperative Cisplatin and Fluorouracil Plus Docetaxel for Locally Advanced Esophageal Cancer: A Multicenter Randomized Phase II Trial
T. Sugase, H. Miyata, T. Kanemura, Norihiro Matsuura +16 more
2025Annals of Gastroenterological Surgery3 citations Open access
Semantic Scholar
Deficiencies in methionine, tryptophan, and niacin remodels intestinal transcriptome and gut microbiota in female mice
T. Hara, Si-Kun Meng, Daisuke Motooka, Yasuko Arao +8 more
2025Scientific Reports3 citations Open access
Semantic Scholar
Second-line tislelizumab versus chemotherapy in Japanese patients with advanced or metastatic esophageal squamous cell carcinoma: subgroup analysis from RATIONALE-302
H. Hara, T. Satoh, T. Kojima, T. Tsushima +8 more
2024Esophagus3 citations Open access
Semantic Scholar
Survival impact of microsatellite instability in stage II gastric cancer patients who received S-1 adjuvant monotherapy after curative resection
Chihiro Sato, H. Kawakami, Ryo Tanaka, H. Satake +7 more
2023Scientific Reports3 citations Open access
Semantic Scholar
Subgroup analyses of safety and efficacy by number and types of prior lines of treatment in FRESCO-2, a global phase III study of fruquintinib in patients with refractory metastatic colorectal cancer.
A. Dasari, S. Lonardi, R. García-Carbonero, E. Élez +16 more
2023Journal of Clinical Oncology3 citations
Semantic Scholar
Histology Classification Highlights Differences in Efficacy of S-1 versus Capecitabine, in Combination with Cisplatin, for HER2-Negative Unresectable Advanced or Recurrent Gastric Cancer with Measurable Disease
H. Kawakami, K. Nishikawa, T. Shimokawa, K. Fujitani +9 more
2022Cancers3 citations Open access
Semantic Scholar
Targeting the regulation of aberrant protein production pathway in gastrointestinal cancer treatment
Hiromichi Sato, K. Sasaki, T. Hara, Shogo Kobayashi +4 more
2022Frontiers in Oncology3 citations Open access
Semantic Scholar
Protocol of OGSG 1901: a phase II trial of ramucirumab plus irinotecan for patients with early relapsed gastric cancer during or after adjuvant docetaxel plus S − 1 therapy
Toshifumi Yamaguchi, H. Kawakami, D. Sakai, Y. Kurokawa +3 more
2022BMC Cancer3 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Y. Doki×16
Invite
Y. Doki — researcher profile on SciRah
H. Eguchi×13
Invite
H. Eguchi — researcher profile on SciRah
T. Yoshino×11
Invite
T. Yoshino — researcher profile on SciRah
H. Hara×11
Invite
H. Hara — researcher profile on SciRah

×11

Invite

T. Nishina — researcher profile on SciRah

Invite

T. Esaki — researcher profile on SciRah

H. Kawakami×10

Invite

H. Kawakami — researcher profile on SciRah

Yoshiaki Nakamura×8

Invite

Yoshiaki Nakamura — researcher profile on SciRah

Invite

H. Yasui — researcher profile on SciRah

Invite

Y. Sunakawa — researcher profile on SciRah

Invite

Y. Kurokawa — researcher profile on SciRah

Invite

D. Sakai — researcher profile on SciRah